Current treatments for scabies and pediculosis.Skin Therapy Lett. 1999; 5(1):1-3.ST
Abstract
Scabies and lice have afflicted man since ancient times. Permethrin is generally the treatment of choice for head lice and scabies, because of its residual effect. Toxicity and absorption are minimal. Ivermectin should be reserved for cases where permethrin fails.
MeSH
Pub Type(s)
Journal Article
Language
eng
PubMed ID
10751840
Citation
Elgart, M L.. "Current Treatments for Scabies and Pediculosis." Skin Therapy Letter, vol. 5, no. 1, 1999, pp. 1-3.
Elgart ML. Current treatments for scabies and pediculosis. Skin Therapy Lett. 1999;5(1):1-3.
Elgart, M. L. (1999). Current treatments for scabies and pediculosis. Skin Therapy Letter, 5(1), 1-3.
Elgart ML. Current Treatments for Scabies and Pediculosis. Skin Therapy Lett. 1999;5(1):1-3. PubMed PMID: 10751840.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Current treatments for scabies and pediculosis.
A1 - Elgart,M L,
PY - 2000/4/7/pubmed
PY - 2000/10/7/medline
PY - 2000/4/7/entrez
SP - 1
EP - 3
JF - Skin therapy letter
JO - Skin Therapy Lett
VL - 5
IS - 1
N2 - Scabies and lice have afflicted man since ancient times. Permethrin is generally the treatment of choice for head lice and scabies, because of its residual effect. Toxicity and absorption are minimal. Ivermectin should be reserved for cases where permethrin fails.
SN - 1201-5989
UR - https://brain.unboundmedicine.com/medline/citation/10751840/Current_treatments_for_scabies_and_pediculosis_
L2 - https://medlineplus.gov/scabies.html
DB - PRIME
DP - Unbound Medicine
ER -